The cause of B12 deficiency, vegetarian diet, pregnancy, and breastfeeding, can impact the dosage and duration of therapy
Research has examined its role in: 3-adrenergic receptor upregulation and adipose tissue sensitisation studies Lipolysis stimulation and plasma glycerol elevation in adipocyte models Lipogenesis inhibition and fat accumulation prevention in diet-induced obesity models Fat oxidation and energy expenditure pathway research Metabolic flexibility and substrate oxidation studies in obese murine models Cartilage regeneration and intra-articular joint biology in osteoarthritis models Safety pharmacology genotoxicity, bioavailability, and plasma kinetics profiling Comparative hGH fragment activity studies alongside AOD9401 and native hGH AOD9604 and Adipose Tissue Research In obese Zucker rats treated with oral AOD9604 at 500 g/kg body weight for 19 days, over 50% reduction in body weight gain was observed compared to controls, accompanied by significantly increased lipolytic activity in adipose tissue
NAD+ (nicotinamide adenine dinucleotide) is a vital molecule in our cells
The most common side effects affect the injection site, and may include: If you experience any of these symptoms, its important to speak with a healthcare professional
However, the question is: are these oral pills as effective as B12 injections in treating these symptoms
